The Super-Donor Phenomenon in Fecal Microbiota Transplantation

Fecal microbiota transplantation (FMT) has become a highly effective bacteriotherapy for recurrent Clostridium difficile infection. Meanwhile the efficacy of FMT for treating chronic diseases associated with microbial dysbiosis has so far been modest with a much higher variability in patient respons...

Full description

Bibliographic Details
Main Authors: Brooke C. Wilson, Tommi Vatanen, Wayne S. Cutfield, Justin M. O'Sullivan
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fcimb.2019.00002/full
id doaj-068dcc66e4c142c393daa072adfb3610
record_format Article
spelling doaj-068dcc66e4c142c393daa072adfb36102020-11-25T01:16:07ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882019-01-01910.3389/fcimb.2019.00002430737The Super-Donor Phenomenon in Fecal Microbiota TransplantationBrooke C. Wilson0Tommi Vatanen1Tommi Vatanen2Wayne S. Cutfield3Justin M. O'Sullivan4The Liggins Institute, University of Auckland, Auckland, New ZealandThe Liggins Institute, University of Auckland, Auckland, New ZealandThe Broad Institute of MIT and Harvard, Cambridge, MA, United StatesThe Liggins Institute, University of Auckland, Auckland, New ZealandThe Liggins Institute, University of Auckland, Auckland, New ZealandFecal microbiota transplantation (FMT) has become a highly effective bacteriotherapy for recurrent Clostridium difficile infection. Meanwhile the efficacy of FMT for treating chronic diseases associated with microbial dysbiosis has so far been modest with a much higher variability in patient response. Notably, a number of studies suggest that FMT success is dependent on the microbial diversity and composition of the stool donor, leading to the proposition of the existence of FMT super-donors. The identification and subsequent characterization of super-donor gut microbiomes will inevitably advance our understanding of the microbial component of chronic diseases and allow for more targeted bacteriotherapy approaches in the future. Here, we review the evidence for super-donors in FMT and explore the concept of keystone species as predictors of FMT success. Possible effects of host-genetics and diet on FMT engraftment and maintenance are also considered. Finally, we discuss the potential long-term applicability of FMT for chronic disease and highlight how super-donors could provide the basis for dysbiosis-matched FMTs.https://www.frontiersin.org/article/10.3389/fcimb.2019.00002/fullfecal microbiota transplantation (FMT)super-donormicrobial dysbiosisclostridium difficile infection (CDI)inflammatory bowel disease (IBD)
collection DOAJ
language English
format Article
sources DOAJ
author Brooke C. Wilson
Tommi Vatanen
Tommi Vatanen
Wayne S. Cutfield
Justin M. O'Sullivan
spellingShingle Brooke C. Wilson
Tommi Vatanen
Tommi Vatanen
Wayne S. Cutfield
Justin M. O'Sullivan
The Super-Donor Phenomenon in Fecal Microbiota Transplantation
Frontiers in Cellular and Infection Microbiology
fecal microbiota transplantation (FMT)
super-donor
microbial dysbiosis
clostridium difficile infection (CDI)
inflammatory bowel disease (IBD)
author_facet Brooke C. Wilson
Tommi Vatanen
Tommi Vatanen
Wayne S. Cutfield
Justin M. O'Sullivan
author_sort Brooke C. Wilson
title The Super-Donor Phenomenon in Fecal Microbiota Transplantation
title_short The Super-Donor Phenomenon in Fecal Microbiota Transplantation
title_full The Super-Donor Phenomenon in Fecal Microbiota Transplantation
title_fullStr The Super-Donor Phenomenon in Fecal Microbiota Transplantation
title_full_unstemmed The Super-Donor Phenomenon in Fecal Microbiota Transplantation
title_sort super-donor phenomenon in fecal microbiota transplantation
publisher Frontiers Media S.A.
series Frontiers in Cellular and Infection Microbiology
issn 2235-2988
publishDate 2019-01-01
description Fecal microbiota transplantation (FMT) has become a highly effective bacteriotherapy for recurrent Clostridium difficile infection. Meanwhile the efficacy of FMT for treating chronic diseases associated with microbial dysbiosis has so far been modest with a much higher variability in patient response. Notably, a number of studies suggest that FMT success is dependent on the microbial diversity and composition of the stool donor, leading to the proposition of the existence of FMT super-donors. The identification and subsequent characterization of super-donor gut microbiomes will inevitably advance our understanding of the microbial component of chronic diseases and allow for more targeted bacteriotherapy approaches in the future. Here, we review the evidence for super-donors in FMT and explore the concept of keystone species as predictors of FMT success. Possible effects of host-genetics and diet on FMT engraftment and maintenance are also considered. Finally, we discuss the potential long-term applicability of FMT for chronic disease and highlight how super-donors could provide the basis for dysbiosis-matched FMTs.
topic fecal microbiota transplantation (FMT)
super-donor
microbial dysbiosis
clostridium difficile infection (CDI)
inflammatory bowel disease (IBD)
url https://www.frontiersin.org/article/10.3389/fcimb.2019.00002/full
work_keys_str_mv AT brookecwilson thesuperdonorphenomenoninfecalmicrobiotatransplantation
AT tommivatanen thesuperdonorphenomenoninfecalmicrobiotatransplantation
AT tommivatanen thesuperdonorphenomenoninfecalmicrobiotatransplantation
AT waynescutfield thesuperdonorphenomenoninfecalmicrobiotatransplantation
AT justinmosullivan thesuperdonorphenomenoninfecalmicrobiotatransplantation
AT brookecwilson superdonorphenomenoninfecalmicrobiotatransplantation
AT tommivatanen superdonorphenomenoninfecalmicrobiotatransplantation
AT tommivatanen superdonorphenomenoninfecalmicrobiotatransplantation
AT waynescutfield superdonorphenomenoninfecalmicrobiotatransplantation
AT justinmosullivan superdonorphenomenoninfecalmicrobiotatransplantation
_version_ 1725151181042352128